SARS-CoV-2 Nucleocapsid protein inhibits anti-viral stress granules formation and Type I/III interferon production via binding to PKR.

Yuna Aoki

[1P-779] SARS-CoV-2 Nucleocapsid protein inhibits anti-viral stress granules formation and Type I/III interferon production via binding to PKR.

^○Yuna Aoki¹, Koji Onomoto¹, Mitsutoshi Yoneyama^1,2 (1.Div. of Mol. Immunol., Med. Mycol. Res. Ctr., Chiba Univ., 2.Res. Inst. of Disaster Med., Chiba Univ.)

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 45th Annual Meeting of the Molecular Biology Society of Japan

[1P-779] SARS-CoV-2 Nucleocapsid protein inhibits anti-viral stress granules formation and Type I/III interferon production via binding to PKR.

Password